Cumberland Pharmaceuticals (CPIX) EBT Margin Growth (1y) (2011 - 2026)
Cumberland Pharmaceuticals (CPIX) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn | -1,585.00 |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn | -177.00 |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn | -27.00 |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn | -356.00 |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn | 436.00 |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn | -629.00 |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn | 208.00 |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - | - |
| 10 | Cumberland Pharmaceuticals | 114.46 Mn | 110.60 Mn | - | -107,666.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -107,666.00 |
| Mar 31, 2026 | -4,506.00 |
| Dec 31, 2025 | 859.00 |
| Sep 30, 2025 | -665.00 |
| Jun 30, 2025 | 435.00 |
| Mar 31, 2025 | 3,296.00 |
| Dec 31, 2024 | 4,834.00 |
| Sep 30, 2024 | -632.00 |
| Jun 30, 2024 | -1,906.00 |
| Mar 31, 2024 | -2,420.00 |
| Dec 31, 2023 | -4,068.00 |
| Sep 30, 2023 | -683.00 |
| Jun 30, 2023 | 2,116.00 |
| Mar 31, 2023 | 1,443.00 |
| Dec 31, 2022 | 2,615.00 |
| Sep 30, 2022 | 1,588.00 |
| Jun 30, 2022 | -2,127.00 |
| Mar 31, 2022 | -923.00 |
| Dec 31, 2021 | -3,527.00 |
| Sep 30, 2021 | -577.00 |